AUPN523995A0 - Method for producing phage display vectors - Google Patents

Method for producing phage display vectors

Info

Publication number
AUPN523995A0
AUPN523995A0 AUPN5239A AUPN523995A AUPN523995A0 AU PN523995 A0 AUPN523995 A0 AU PN523995A0 AU PN5239 A AUPN5239 A AU PN5239A AU PN523995 A AUPN523995 A AU PN523995A AU PN523995 A0 AUPN523995 A0 AU PN523995A0
Authority
AU
Australia
Prior art keywords
phage display
display vectors
producing phage
producing
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN5239A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRC for Biopharmaceutical Research Pty Ltd
Original Assignee
CRC for Biopharmaceutical Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRC for Biopharmaceutical Research Pty Ltd filed Critical CRC for Biopharmaceutical Research Pty Ltd
Priority to AUPN5239A priority Critical patent/AUPN523995A0/en
Publication of AUPN523995A0 publication Critical patent/AUPN523995A0/en
Priority to JP9510704A priority patent/JPH10511001A/en
Priority to AU67823/96A priority patent/AU6782396A/en
Priority to CA002231045A priority patent/CA2231045A1/en
Priority to EP96928283A priority patent/EP0850309A1/en
Priority to PCT/AU1996/000555 priority patent/WO1997009436A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AUPN5239A 1995-09-05 1995-09-05 Method for producing phage display vectors Abandoned AUPN523995A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPN5239A AUPN523995A0 (en) 1995-09-05 1995-09-05 Method for producing phage display vectors
JP9510704A JPH10511001A (en) 1995-09-05 1996-09-05 Method for producing phage display vector
AU67823/96A AU6782396A (en) 1995-09-05 1996-09-05 Method for producing phage display vectors
CA002231045A CA2231045A1 (en) 1995-09-05 1996-09-05 Method for producing phage display vectors
EP96928283A EP0850309A1 (en) 1995-09-05 1996-09-05 Method for producing phage display vectors
PCT/AU1996/000555 WO1997009436A1 (en) 1995-09-05 1996-09-05 Method for producing phage display vectors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN5239A AUPN523995A0 (en) 1995-09-05 1995-09-05 Method for producing phage display vectors

Publications (1)

Publication Number Publication Date
AUPN523995A0 true AUPN523995A0 (en) 1995-09-28

Family

ID=3789568

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN5239A Abandoned AUPN523995A0 (en) 1995-09-05 1995-09-05 Method for producing phage display vectors

Country Status (5)

Country Link
EP (1) EP0850309A1 (en)
JP (1) JPH10511001A (en)
AU (1) AUPN523995A0 (en)
CA (1) CA2231045A1 (en)
WO (1) WO1997009436A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
US6143557A (en) * 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
NZ312332A (en) 1995-06-07 2000-01-28 Life Technologies Inc Recombinational cloning using engineered recombination sites
US6051409A (en) 1995-09-25 2000-04-18 Novartis Finance Corporation Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
NZ520579A (en) 1997-10-24 2004-08-27 Invitrogen Corp Recombinational cloning using nucleic acids having recombination sites and methods for synthesizing double stranded nucleic acids
US7102055B1 (en) 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
ATE454459T1 (en) 1997-11-18 2010-01-15 Pioneer Hi Bred Int MOBILIZATION OF A VIRAL GENOME FROM T-DNA THROUGH SITE-SPECIFIC RECOMBINATION SYSTEMS
AU745960C (en) 1997-11-18 2003-09-18 Pioneer Hi-Bred International, Inc. A novel method for the integration of foreign DNA into eukaryoticgenomes
AU760113C (en) 1997-11-18 2004-04-22 Pioneer Hi-Bred International, Inc. Compositions and methods for genetic modification of plants
AU5122499A (en) 1998-07-27 2000-02-21 Genentech Inc. Improved transformation efficiency in phage display through modification of a coat protein
AU774643B2 (en) 1999-03-02 2004-07-01 Invitrogen Corporation Compositions and methods for use in recombinational cloning of nucleic acids
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
US20030235814A1 (en) * 2002-06-19 2003-12-25 Los Alamos National Laboratory Compositions and methods for selecting open reading frames
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
ATE523603T1 (en) 2008-11-21 2011-09-15 Chimera Biotec Gmbh CONJUGATE COMPLEXES FOR ANALYTE DETECTION
US9712606B2 (en) * 2014-05-21 2017-07-18 Nasdaq Technology Ab Efficient and reliable host distribution of totally ordered global state
JP7072524B2 (en) 2016-12-26 2022-05-20 Ｊｃｒファーマ株式会社 Fusion protein containing BDNF
AU2017385288B9 (en) 2016-12-26 2022-01-13 Jcr Pharmaceuticals Co., Ltd. Novel anti-human transferrin receptor antibody capable of penetrating blood-brain barrier
EA202091816A1 (en) 2018-02-05 2020-10-26 Джей Си Ар ФАРМАСЬЮТИКАЛЗ КО., ЛТД. METHOD OF DRUG DELIVERY TO MUSCLE

Also Published As

Publication number Publication date
JPH10511001A (en) 1998-10-27
CA2231045A1 (en) 1997-03-13
WO1997009436A1 (en) 1997-03-13
EP0850309A1 (en) 1998-07-01

Similar Documents

Publication Publication Date Title
AUPN523995A0 (en) Method for producing phage display vectors
AU4716296A (en) Process for producing thietanones
AU4698396A (en) Process for modifying surfaces
EP1271234A3 (en) Method of forming images
EP0772180A3 (en) Video display apparatus
AU5839996A (en) Frame synchronization method
AU6666196A (en) Cooling apparatus
AU691390B2 (en) Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines
EP0776070A3 (en) Connecting apparatus
EP0753415A3 (en) Image forming method
AU4882996A (en) Method for producing fluoroalkanes
AU7591896A (en) Method for motion estimation
HUP9602960A2 (en) Process for producing alkylcarbazates
AU7414196A (en) Process for producing etoposide
IL119235A (en) Display forming method
AU1118797A (en) Process
AU6782396A (en) Method for producing phage display vectors
HUP9602988A2 (en) Process for producing 2-chloracrylnitril
AU1177197A (en) Improved process for producing 5-formylthiazol
AU1101797A (en) Method for making fluoroalkanols
AU5271296A (en) Novel method
PL323389A1 (en) Caprolaktam producing method
AU7694596A (en) Process for producing 1-aminohydantoin
AU5485596A (en) Process for making 1-hydroxybisphosphonates
AU1138397A (en) Novel method